20 Most Shorted Stocks — Short Interest Report July 9, 2026

Overview of Short Interest

As of July 9, 2026, a variety of stocks across multiple sectors have garnered significant short interest. These stocks are often viewed as risky by investors, with high short ratios indicating a bearish sentiment. Below, we analyze the top 20 most shorted stocks, their short interests, and potential catalysts for a squeeze.

1. Groupon Inc (GRPN) - **Short Interest**: 55.77% of float - **Days to Cover**: 7.5 - **Bearish Thesis**: Groupon has faced declining revenues and heavy competition in the discount retail space. - **Squeeze Catalysts**: Upcoming earnings report on August 5, 2026. - **Media Activity**: Analysts have been vocal about the company's struggles, further pressuring the stock. - **Important Dates**: Earnings on August 5, 2026. - **Squeeze Risk Score**: 8/10

2. Battalion Oil Corp. (BATL) - **Short Interest**: 42.88% of float - **Days to Cover**: 4.2 - **Bearish Thesis**: Concerns over oil price volatility and regulatory challenges have led to bearish sentiment. - **Squeeze Catalysts**: Potential merger news could create upward pressure. - **Media Activity**: Limited coverage, mostly negative. - **Important Dates**: None imminent. - **Squeeze Risk Score**: 6/10

3. C3.ai Inc (AI) - **Short Interest**: 42.88% of float - **Days to Cover**: 5.0 - **Bearish Thesis**: High valuation amidst slowing AI adoption has led to skepticism. - **Squeeze Catalysts**: Upcoming AI conference in September could serve as a catalyst. - **Media Activity**: Mixed reviews from analysts, with some bullish on AI's long-term potential. - **Important Dates**: AI conference in September 2026. - **Squeeze Risk Score**: 7/10

4. 1-800-FLOWERS.COM, Inc. (FLWS) - **Short Interest**: 39.91% of float - **Days to Cover**: 3.5 - **Bearish Thesis**: Supply chain issues and seasonal sales declines have hurt performance. - **Squeeze Catalysts**: Valentine's Day sales results could revive interest. - **Media Activity**: Increased social media chatter around holiday sales. - **Important Dates**: Next earnings report on February 10, 2027. - **Squeeze Risk Score**: 5/10

5. SoundHound AI Inc (SOUN) - **Short Interest**: 37.90% of float - **Days to Cover**: 6.0 - **Bearish Thesis**: Competitive pressures in the AI voice recognition space have raised doubts. - **Squeeze Catalysts**: New product launch expected in Q4 2026. - **Media Activity**: Recent tech reviews have been mixed, causing volatility. - **Important Dates**: Product launch in Q4 2026. - **Squeeze Risk Score**: 7/10

6. Sphere Entertainment Co. (SPHR) - **Short Interest**: 37.18% of float - **Days to Cover**: 4.0 - **Bearish Thesis**: Concerns over declining attendance in entertainment venues. - **Squeeze Catalysts**: Potential acquisition rumors could create a squeeze. - **Media Activity**: Increased focus on live entertainment trends. - **Important Dates**: None imminent. - **Squeeze Risk Score**: 6/10

7. Xponential Fitness, Inc. (XPOF) - **Short Interest**: 37.11% of float - **Days to Cover**: 4.5 - **Bearish Thesis**: The fitness industry is recovering slowly post-pandemic, raising doubts. - **Squeeze Catalysts**: New studio openings planned for Q3 2026. - **Media Activity**: Positive influencer reviews on social media could help. - **Important Dates**: Studio openings in July 2026. - **Squeeze Risk Score**: 5/10

8. ARS Pharmaceuticals Inc (SPRY) - **Short Interest**: 37.04% of float - **Days to Cover**: 3.8 - **Bearish Thesis**: Concerns over drug approval timelines have pressured shares. - **Squeeze Catalysts**: FDA decision on upcoming drug could provide a boost. - **Media Activity**: Analyst downgrades have dampened sentiment. - **Important Dates**: FDA decision expected in August 2026. - **Squeeze Risk Score**: 8/10

9. Evgo Inc (EVGO) - **Short Interest**: 34.79% of float - **Days to Cover**: 3.0 - **Bearish Thesis**: Concerns over scalability and competition in electric vehicle charging. - **Squeeze Catalysts**: Partnerships with major automakers could shift sentiment. - **Media Activity**: Increasing coverage on EV trends may provide support. - **Important Dates**: None imminent. - **Squeeze Risk Score**: 5/10

10. LifeVantage Corporation (LFVN) - **Short Interest**: 34.31% of float - **Days to Cover**: 2.1 - **Bearish Thesis**: Declining sales and increasing competition in health products. - **Squeeze Catalysts**: New product launch in Q4 2026. - **Media Activity**: Limited media coverage; mostly negative. - **Important Dates**: Product launch in Q4 2026. - **Squeeze Risk Score**: 4/10

11. Hertz Global Holdings Inc (HTZ) - **Short Interest**: 34.19% of float - **Days to Cover**: 3.2 - **Bearish Thesis**: High debt levels and ongoing market volatility. - **Squeeze Catalysts**: Q2 earnings report on August 1, 2026. - **Media Activity**: Analysts have been wary, citing debt concerns. - **Important Dates**: Earnings on August 1, 2026. - **Squeeze Risk Score**: 6/10

12. Lucid Group, Inc. (LCID) - **Short Interest**: 33.83% of float - **Days to Cover**: 5.4 - **Bearish Thesis**: Production delays and increasing competition in EV market. - **Squeeze Catalysts**: Upcoming vehicle delivery announcement. - **Media Activity**: Positive reviews of new model could help. - **Important Dates**: Vehicle delivery announcement expected in July 2026. - **Squeeze Risk Score**: 7/10

13. Fluence Energy, Inc. (FLNC) - **Short Interest**: 32.57% of float - **Days to Cover**: 3.6 - **Bearish Thesis**: Slow adoption of energy storage solutions amid energy transition. - **Squeeze Catalysts**: New contracts could drive stock up. - **Media Activity**: Limited coverage; mostly negative. - **Important Dates**: None imminent. - **Squeeze Risk Score**: 5/10

14. TTEC Holdings, Inc. (TTEC) - **Short Interest**: 32.22% of float - **Days to Cover**: 4.0 - **Bearish Thesis**: Slow revenue growth in customer experience sector. - **Squeeze Catalysts**: New client wins could shift sentiment. - **Media Activity**: Increasing focus on customer experience trends. - **Important Dates**: None imminent. - **Squeeze Risk Score**: 4/10

15. Recursion Pharmaceuticals, Inc. (RXRX) - **Short Interest**: 32.22% of float - **Days to Cover**: 3.5 - **Bearish Thesis**: Long timelines for drug development causing skepticism. - **Squeeze Catalysts**: Upcoming clinical trial results. - **Media Activity**: Analysts have been cautiously optimistic. - **Important Dates**: Clinical results expected in August 2026. - **Squeeze Risk Score**: 6/10

16. Purecycle Technologies Inc (PCT) - **Short Interest**: 31.67% of float - **Days to Cover**: 2.8 - **Bearish Thesis**: High operational costs and scalability issues. - **Squeeze Catalysts**: Potential strategic partnerships could improve outlook. - **Media Activity**: Limited positive coverage. - **Important Dates**: None imminent. - **Squeeze Risk Score**: 4/10

17. Urban One, Inc. (UONE) - **Short Interest**: 31.40% of float - **Days to Cover**: 2.0 - **Bearish Thesis**: Declining advertising revenues affecting growth. - **Squeeze Catalysts**: New content partnerships could drive revenue. - **Media Activity**: Limited media presence. - **Important Dates**: None imminent. - **Squeeze Risk Score**: 3/10

18. Serve Robotics Inc. (SERV) - **Short Interest**: 31.02% of float - **Days to Cover**: 3.2 - **Bearish Thesis**: High competition in the robotics delivery space. - **Squeeze Catalysts**: New partnerships with delivery companies could help. - **Media Activity**: Increased focus on robotics in logistics. - **Important Dates**: None imminent. - **Squeeze Risk Score**: 5/10

19. GeneDx Holdings Corp. (WGS) - **Short Interest**: 30.92% of float - **Days to Cover**: 3.4 - **Bearish Thesis**: Market skepticism on genetic testing growth. - **Squeeze Catalysts**: New product offerings expected in Q4 2026. - **Media Activity**: Limited coverage; mostly negative. - **Important Dates**: Product offerings in Q4 2026. - **Squeeze Risk Score**: 4/10

Summary ### Top 3 Most Dangerous Shorts 1. **Groupon Inc (GRPN)**: High short interest with imminent earnings could lead to a substantial squeeze if results are better than expected. 2. **Recursion Pharmaceuticals, Inc. (RXRX)**: Upcoming clinical trial results could either validate the short thesis or prompt a rally. 3. **C3.ai Inc (AI)**: High valuation concerns could be mitigated by positive market sentiment during the AI conference.

Short of the Week **Groupon Inc (GRPN)** is the most at risk for a squeeze, given its high short interest and approaching earnings date.

Pattern Analysis The current landscape shows a mix of sector-wide short themes, particularly in technology and consumer discretionary, alongside stock-specific issues, such as operational challenges and regulatory hurdles.

Educational content only. Not financial advice. DYOR.